Umang Swami,
MD
Languages Spoken: English
Umang Swami is an Assistant Professor in Department of Oncology at Huntsman Cancer Institute with a focus on genitourinary cancers. He completed his Medical School from Sawai Man Singh Medical College, India. Thereafter he worked as a Visiting Scientist at Montefiore-Einstein Cancer Center, NY and collaborated on phase I studies of novel drugs and regimens for patients with refractory or advanced solid tumors. He did his residency training in Internal Medicine at St. Barnabas Hospital, NY, Hematology-Oncology fellowship from University of Iowa and completed MS in Clinical Investigations from College of Public Health at University of Iowa.
He has published more than 60 articles in peer reviewed journals and has presented his research at various international conferences including ASCO, AACR and ASBMT. He is a reviewer and editor of multiple journals and member of various professional societies like ASCO, AACR, ASH and ACP. He serves on the ASCO guideline panels for systemic therapy in melanoma, management of immune-related adverse events and Multi-Site Guideline Advisory Group. He is a current member of Institutional Review Board at University of Utah. He was also a member of transfusion subcommittee and Holden Comprehensive Cancer Center Career Enhancement Advisory Committee at University of Iowa. He has mentored medical students, residents and fellows interested in oncology research.
Clinical Locations
Clinic 2B, GU
801-587-4644
Fax: (801) 585-0155
801-587-4644
Specialties
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Assistant Professor |
| Academic Divisions | Oncology |
| Board Certification | American Board of Internal Medicine American Board of Internal Medicine (Sub: Medical Oncology) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.8/ 5
Care provider's effort to include me in decisions
4.8/ 5
Wait time at clinic
4.4/ 5
Care provider's concern for questions & worries
4.8/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
April 25, 2022
HUNTSMAN CANCER CENTER
Good
UofU Patient
April 18, 2022
HUNTSMAN CANCER CENTER
Dr. Swaim is such a caring doctor.
UofU Patient
April 11, 2022
HUNTSMAN CANCER CENTER
Good
UofU Patient
March 29, 2022
HUNTSMAN CANCER CENTER
It seemed there should be more time spent describing the good and bad of all prescribed treatments
UofU Patient
March 27, 2022
HUNTSMAN CANCER CENTER
I can't rate them highly enough
UofU Patient
March 21, 2022
HUNTSMAN CANCER CENTER
Dr. Swami is very caring and provides excellent details related to my condition.
UofU Patient
March 14, 2022
HUNTSMAN CANCER CENTER
We love Dr swami and his staff
UofU Patient
March 13, 2022
SUGAR HOUSE HEALTH CENTER
I consider stage 4 cancer as being very serious and deserving of the best care possible. I am very pleased with my visit and feel that I have made the best choice.
UofU Patient
February 19, 2022
HUNTSMAN CANCER CENTER
Didn't enjoy the virtual visit but it was a necessity and got the job done
UofU Patient
January 15, 2022
HUNTSMAN CANCER CENTER
He always answers our questions
UofU Patient
January 04, 2022
SUGAR HOUSE HEALTH CENTER
The support staff wasvexcellent
UofU Patient
December 21, 2021
HUNTSMAN CANCER CENTER
Good
UofU Patient
December 14, 2021
HUNTSMAN CANCER CENTER
Care provider was excellent!
UofU Patient
December 08, 2021
HUNTSMAN CANCER CENTER
Great!!!!!!!!
UofU Patient
November 30, 2021
HUNTSMAN CANCER CENTER
Had to wait 45 minutes for Dr. Swami to join the conversation.
UofU Patient
November 13, 2021
HUNTSMAN CANCER CENTER
Everything has been really good
UofU Patient
October 31, 2021
SUGAR HOUSE HEALTH CENTER
We felt there were few options but we also understand the cancer he has and what the treatment entailed
UofU Patient
October 18, 2021
HUNTSMAN CANCER CENTER
Dr Swami and his assistant were very forthright in their analysis an description of the coming events to further evaluate this condition.
UofU Patient
September 08, 2021
HUNTSMAN CANCER CENTER
Very good experience. He is very concerned, professional, good listener, knowledgeable, and Im very thankful I have him as my doctor.
UofU Patient
August 04, 2021
HUNTSMAN CANCER CENTER
My Dr Swami is the best. He is very thorough. I want to try to push treatment and sometimes he tells me it's okay to slow down and not feel so sick from the side effects. He is always comforting and positive. I know he is in the battle with me.
UofU Patient
August 02, 2021
SUGAR HOUSE HEALTH CENTER
Good
UofU Patient
July 17, 2021
HUNTSMAN CANCER CENTER
They seem to be curing me and I can't imagine how they could do any better than they have so far.
UofU Patient
June 19, 2021
SUGAR HOUSE HEALTH CENTER
good
UofU Patient
June 18, 2021
SUGAR HOUSE HEALTH CENTER
the doctors were excellent
UofU Patient
June 05, 2021
HUNTSMAN CANCER CENTER
very good experience.
UofU Patient
May 27, 2021
HUNTSMAN CANCER CENTER
I was in ICU and later on a ward.
UofU Patient
May 10, 2021
HUNTSMAN CANCER CENTER
they are the best care team.
UofU Patient
April 14, 2021
HUNTSMAN CANCER CENTER
I like that Dr. Swami takes the time to explain the questions that we have regarding my treatments.He makes sure that we are comfortable with his decisions . I am very happy to have him as my dr.
UofU Patient
April 12, 2021
HUNTSMAN CANCER CENTER
good
UofU Patient
March 24, 2021
HUNTSMAN CANCER CENTER
very good experience overall.
UofU Patient
March 20, 2021
HUNTSMAN CANCER CENTER
very good experience
UofU Patient
March 12, 2021
HUNTSMAN CANCER CENTER
I am very pleased with Dr. Swami's responses to my needs. He answered my questions and cleared up some information I had previously misunderstood.
UofU Patient
March 09, 2021
HUNTSMAN CANCER CENTER
I felt like I was well taken care of.
UofU Patient
March 05, 2021
HUNTSMAN CANCER CENTER
no bad experiences
UofU Patient
January 31, 2021
HUNTSMAN CANCER CENTER
I am very impressed by the thoroughness of all of the personnel in their dealings with me
UofU Patient
January 31, 2021
HUNTSMAN CANCER CENTER
Dr. Swami is very good at listening to my concerns and suggestions.
UofU Patient
January 27, 2021
HUNTSMAN CANCER CENTER
I felt that I could trust them.
UofU Patient
January 17, 2021
HUNTSMAN CANCER CENTER
Dr Swami asked me to stop taking my Atorvastatin in the hallway after we had left the room and we did not have time or opportunity to discuss the reason.
UofU Patient
January 09, 2021
HUNTSMAN CANCER CENTER
Dr Swami showed me what was going on and answered all my questions. I felt like I could trust his judgement and plan to do exactly as he thinks best.
UofU Patient
January 01, 2021
HUNTSMAN CANCER CENTER
My opinions are taken into consideration on any treatment the doc proposed.
UofU Patient
December 25, 2020
SUGAR HOUSE HEALTH CENTER
good
UofU Patient
November 29, 2020
HUNTSMAN CANCER CENTER
Could benefit from more of an explanation of what the lab results were, a summary explanation of what has taken place so far, and summary explanation of what was next. Although MRI wasn't involved in this visit, would benefit from an explanation of what they are showing, and not trying to flip through MRI scans at the moment of the visit. Would also like to see more documented information and plans rather than a few minutes of just a verbal conversational visit.
UofU Patient
November 22, 2020
SUGAR HOUSE HEALTH CENTER
good
UofU Patient
November 14, 2020
SUGAR HOUSE HEALTH CENTER
Very good doctor.
UofU Patient
November 10, 2020
HUNTSMAN CANCER CENTER
very good experience
Umang Swami is an Assistant Professor in Department of Oncology at Huntsman Cancer Institute with a focus on genitourinary cancers. He completed his Medical School from Sawai Man Singh Medical College, India. Thereafter he worked as a Visiting Scientist at Montefiore-Einstein Cancer Center, NY and collaborated on phase I studies of novel drugs and regimens for patients with refractory or advanced solid tumors. He did his residency training in Internal Medicine at St. Barnabas Hospital, NY, Hematology-Oncology fellowship from University of Iowa and completed MS in Clinical Investigations from College of Public Health at University of Iowa.
He has published more than 60 articles in peer reviewed journals and has presented his research at various international conferences including ASCO, AACR and ASBMT. He is a reviewer and editor of multiple journals and member of various professional societies like ASCO, AACR, ASH and ACP. He serves on the ASCO guideline panels for systemic therapy in melanoma, management of immune-related adverse events and Multi-Site Guideline Advisory Group. He is a current member of Institutional Review Board at University of Utah. He was also a member of transfusion subcommittee and Holden Comprehensive Cancer Center Career Enhancement Advisory Committee at University of Iowa. He has mentored medical students, residents and fellows interested in oncology research.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Assistant Professor |
| Academic Divisions | Oncology |
| Board Certification | American Board of Internal Medicine American Board of Internal Medicine (Sub: Medical Oncology) |
Research Interests
- Prostate Cancer
- Genitourinary Cancers
- Clinical Trials
- Melanoma
- Bladder Cancer
- Kidney Cancer
- Cancer Immunotherapy
Education History
| Fellowship | University of Iowa Hospitals and Clinics Hematology Oncology Fellow, 2019 |
| Externship | National Cancer Institute Cancer Therapy Evaluation Program Elective Externship, 2018 |
| Graduate Training | University of Iowa College of Public Health Clinical Investigation M.S.C.I, 2018 |
| Residency | St. Barnabas Hospital Internal Medicine Resident, 2014 |
| Professional Medical | Sawai Man Singh Medical College Medicine/Surgery M.B.B.S., 2007 |
Selected Publications - Journal Articles
Journal Article
- Li H, Sahu KK, Kumar SA, Nordblad B, Sayegh N, Tripathi N, Thomas VM, Gupta S, Maughan BL, Agarwal N, Swami U (2022). A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers. Heliyon, e10583.
- Swami U, Graf RP, Nussenzveig RH, Fisher V, Tukachinsky H, Schrock AB, Li G, Ross JS, Sayegh N, Tripathi N, Mathew Thomas V, Oxnard GR, Antonarakis ES, Agarwal N (2022). SPOP mutations as a Predictive Biomarker for Androgen Receptor-Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clin Cancer Res.
- Zimmerman R, Bilen MA, Heath EI, Nandagopal L, Swami U, Kessel A, Jaeger E, Wesolowski S, Hernanadez EJ, Chipman J, Mack A, Ravindranathan D, Maughan BL, Nussenzveig R, Yandell M, Kohli M, Lilly MB, Sartor AO, Agarwal N, Barata PC (2022). Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race. Oncologist.
- Tripathi N, Jo Y, Tripathi A, Sayegh N, Li H, Nussenzveig R, Haaland B, Thomas VM, Gupta S, Maughan BL, Swami U, Pal SK, Grivas P, Agarwal N, Sirohi D (2022). Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma. Urol Oncol.
- Sayegh N, Tripathi N, Nussenzveig RH, Thomas VM, Tandar C, Goel D, Nordblad B, Sahu KK, Li H, L Maughan B, Agarwal N, Swami U (2022). Survival of Patients with Metastatic Prostate Cancer After Disease Progression on an Androgen Receptor Axis-Targeted Therapy Given in the Metastatic Castration-Sensitive Versus Metastatic Castration-Resistant Prostate Cancer Setting. Eur Urol Focus.
Review
Global Impact
Education History
| Professional Medical | Sawai Man Singh Medical College Medicine/Surgery M.B.B.S. |